Pub Date : 2020-05-07DOI: 10.1093/oso/9780197514993.003.0003
Nicole Hassoun
The third chapter presents the book’s new proposal for addressing the access to medicines problem. It suggests that by collecting and analyzing data on global health, people can come up with new ways to improve poor people’s access to essential drugs and technologies. It suggests utilizing information about medicines’ global health impact (organized by drug, disease, country, and company) to create incentives for positive change. One possibility is to give pharmaceutical companies with the most impactful drugs a Global Health Impact label to use on all their products. Highly rated companies will have an incentive to use the label to get a larger share of the market. Further, socially responsible investment companies could include Global Health Impact companies in their portfolios. Finally, having a Global Health Impact certification system for pharmaceutical companies would open the door to all kinds of fruitful social activism. One possibility is a Global Health Impact licensing campaign. Pharmaceutical companies rely, to a large extent, on university research and development. So, if universities allow only certified companies to benefit from their technology, companies will have an incentive to abide by Global Health Impact standards.
{"title":"Promoting Global Health","authors":"Nicole Hassoun","doi":"10.1093/oso/9780197514993.003.0003","DOIUrl":"https://doi.org/10.1093/oso/9780197514993.003.0003","url":null,"abstract":"The third chapter presents the book’s new proposal for addressing the access to medicines problem. It suggests that by collecting and analyzing data on global health, people can come up with new ways to improve poor people’s access to essential drugs and technologies. It suggests utilizing information about medicines’ global health impact (organized by drug, disease, country, and company) to create incentives for positive change. One possibility is to give pharmaceutical companies with the most impactful drugs a Global Health Impact label to use on all their products. Highly rated companies will have an incentive to use the label to get a larger share of the market. Further, socially responsible investment companies could include Global Health Impact companies in their portfolios. Finally, having a Global Health Impact certification system for pharmaceutical companies would open the door to all kinds of fruitful social activism. One possibility is a Global Health Impact licensing campaign. Pharmaceutical companies rely, to a large extent, on university research and development. So, if universities allow only certified companies to benefit from their technology, companies will have an incentive to abide by Global Health Impact standards.","PeriodicalId":347061,"journal":{"name":"Global Health Impact","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115418738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-05-07DOI: 10.1093/oso/9780197514993.003.0004
Nicole Hassoun
If Global Health Impact labeling is successful, it will give companies a reason to produce drugs that will save millions of lives. One might wonder, however, whether consumers have any moral obligation to purchase goods from Global Health Impact–certified companies or whether purchasing these goods is even morally permissible. The fourth chapter suggests that, if the proposal is implemented, there is reason to purchase goods from Global Health Impact–certified companies. It defends something along the lines of this argument: (1) pharmaceutical companies violate rights and (2) do not do enough to address the access to medicines issue, so (3) if the Global Health Impact initiative helps rectify these problems, people should generally purchase goods from certified companies.
{"title":"Individual Responsibility for Promoting Global Health","authors":"Nicole Hassoun","doi":"10.1093/oso/9780197514993.003.0004","DOIUrl":"https://doi.org/10.1093/oso/9780197514993.003.0004","url":null,"abstract":"If Global Health Impact labeling is successful, it will give companies a reason to produce drugs that will save millions of lives. One might wonder, however, whether consumers have any moral obligation to purchase goods from Global Health Impact–certified companies or whether purchasing these goods is even morally permissible. The fourth chapter suggests that, if the proposal is implemented, there is reason to purchase goods from Global Health Impact–certified companies. It defends something along the lines of this argument: (1) pharmaceutical companies violate rights and (2) do not do enough to address the access to medicines issue, so (3) if the Global Health Impact initiative helps rectify these problems, people should generally purchase goods from certified companies.","PeriodicalId":347061,"journal":{"name":"Global Health Impact","volume":"151 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116575737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-05-07DOI: 10.1093/oso/9780197514993.003.0002
Nicole Hassoun
Some maintain that people lack a human right to health because this right cannot provide guidance for distributing scarce resources. Even if the skeptics are right on this point, the second chapter suggests that is not a reason to reject the right; the role of the human right to health is to provide a kind of hope that can foster the virtue of creative resolve. This resolve is a fundamental commitment to finding creative solutions to what appear to be tragic dilemmas. Rather than helping one decide how to ration scarce resources, the human right to health provides reason to find ways to fulfill everyone’s claims. The hope this right provides gives us a response to apparent tragedy in motivating us to search for ways of avoiding it—rather than an account of distributive justice.
{"title":"The Human Right to Health and the Virtue of Creative Resolve","authors":"Nicole Hassoun","doi":"10.1093/oso/9780197514993.003.0002","DOIUrl":"https://doi.org/10.1093/oso/9780197514993.003.0002","url":null,"abstract":"Some maintain that people lack a human right to health because this right cannot provide guidance for distributing scarce resources. Even if the skeptics are right on this point, the second chapter suggests that is not a reason to reject the right; the role of the human right to health is to provide a kind of hope that can foster the virtue of creative resolve. This resolve is a fundamental commitment to finding creative solutions to what appear to be tragic dilemmas. Rather than helping one decide how to ration scarce resources, the human right to health provides reason to find ways to fulfill everyone’s claims. The hope this right provides gives us a response to apparent tragedy in motivating us to search for ways of avoiding it—rather than an account of distributive justice.","PeriodicalId":347061,"journal":{"name":"Global Health Impact","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121575072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：